Abstract:12103 Background: RT/RTCT during HNSCC treatment is associated with a high rate of severe dysphagia requiring the use of a FT. Randomized trials have failed to show a benefit of a prophylactic enteral nutrition in case of RTCT. Even when indicated, numerous patients refuse the placement of a FT. We assessed the factors associated with FT acceptance and outcomes between patients that had a FT, or not. Methods: The monocentric NutriNeck study (NCT02900963) recruited all HNSCC patients between 2014 and 2018 treated by RT/RTCT for curative intent. Patients fed by enteral nutrition before RT initiation were excluded. A daily monitoring of the weight and a weekly clinical evaluation during RT/RTCT were performed, as well as a quality-of-life (QoL) assessment using QLQ-C30 and HN 35 at baseline, 3 and 9 months after the end of treatment. A nutritional intervention by FT was systematically proposed in case of 2 kg weight loss under treatment or severe dysphagia. Patients were considered into 3 groups: FT indication and acceptation, FT indication but refusal, no FT indication. A p value < 0.05 was considered significant. Results: Among the 250 HNSCC patients included, 119 (48%) were treated by RT and 131 (52%) by RTCT. Overall, 114 patients (46%) accepted FT, 48 (19%) refused an indicated FT and 88 (35%) had no FT indication. In multivariable analysis, the only factor associated with an indication of a FT tube was having a RTCT vs a RT (p < 0.0001). Among the 162 patients (65%) with FT indication, in multivariate analysis factors associated with FT placement acceptance were having a RTCT (p = 0.01), being treated by exclusive RT+/-CT instead of adjuvant RT/CT (p = 0.05), having a tumor of the oral cavity (p = 0.02), having at baseline a decreased role functioning score (p = 0.04). When using linear mixed models for QoL analyses, over time role functioning, social functioning and pain were the only categories significantly different between patients that accepted FT and patients that refused or had no FT indication. At the end of treatment, median weight loss was significantly more important among patients with FT indication, compared to patients without FT indication (-4% vs -1%, respectively, p < 0.0001). This difference remained significant 3 and 9 months after the end of treatment. Among patients with FT indication, there was no difference in case of FT placement acceptance or refusal regarding grade 3 toxicities during treatment or weight loss at the end of treatment, after 3 and 9 months of follow-up. Conclusions: One third of the patients with an indicated FT have refused the FT placement, and did as well as those that accepted. Using baseline QoL items such as decreased role or social functioning, or increased pain may help identifying a subgroup of patients for which an earlier FT placement should be considered.

Effect of prophylactic tube feeding in head and neck cancer patients with high Mallampati score undergoing definitive concurrent chemoradiotherapy

Consensus and clinical recommendations for nutritional intervention for head and neck cancer patients undergoing chemoradiotherapy in Taiwan

Improved Prognosis with Induction Chemotherapy in Pathological Complete Responders after Trimodality Treatment for Esophageal Squamous Cell Carcinoma: Hypothesis Generating for Adjuvant Treatment.

Prognostication and Optimal Criteria of Circumferential Margin Involvement for Esophageal Cancer after Chemoradiation and Esophagectomy

Anti-PD-(L)1-Based Neoadjuvant Therapy in Head and Neck Carcinoma: a Meta-analysis of Prospective Clinical Trials.

The Management of Metastatic Neck Nodes Following Induction Chemotherapy in N2/3 Classification Hypopharyngeal Carcinoma

Profiling Protein Markers Associated with the Sensitivity to Concurrent Chemoradiotherapy in Human Cervical Carcinoma.

Prognosis of Pneumonia in Head and Neck Squamous Cell Carcinoma Patients Who Received Concurrent Chemoradiotherapy

Predictors of Gastrostomy Tube Placement in Head and Neck Cancer Patients Undergoing Radiation or Chemoradiotherapy: A Systematic Review

Analysis of Swallowing Functional Preservation by Surgical Versus CRT After Induction Chemotherapy for Oropharyngeal Cancer

Comparative Effects Of Different Enteral Feeding Methods In Head And Neck Cancer Patients Receiving Radiotherapy Or Chemoradiotherapy: A Network Meta-Analysis

Predictive effect of pretreatment nutritional risk and GLIM-defined malnutrition on the nutrition impact symptom clusters in patients with head and neck cancer undergoing radiotherapy.

Effects of Enteral Nutrition on Patients With Oesophageal Carcinoma Treated With Concurrent Chemoradiotherapy: A Prospective, Multicentre, Randomised, Controlled Study

A Multicenter Prospective Observational Study of Nutritional Status in Locally Advanced Nasopharynx Cancer Treated by Induction Chemotherapy and Chemoradiotherapy

Effectiveness of an evidence-based swallowing facilitation strategy for patients undergoing radiotherapy for head and neck cancer: a study protocol for a randomised controlled trial

Prospective evaluation of factors associated with acceptance of feeding tube (FT) placement and clinical outcomes during radiation therapy (RT) or radiochemotherapy (RTCT) for head and neck squamous cell carcinoma (HNSCC).

A preliminary Study on the Effect of Head and Neck Chemoradiotherapy on Systematic Immunity.

Locally advanced head and neck squamous cell carcinoma treatment efficacy and safety: a systematic review and network meta-analysis

Circulating p16-Positive and p16-Negative Tumor Cells Serve as Independent Prognostic Indicators of Survival in Patients with Head and Neck Squamous Cell Carcinomas

Effect of Neoadjuvant Chemotherapy Followed by Concurrent Chemoradiotherapy on Nutritional Status in Locoregionally Advanced Nasopharyngeal Carcinoma Patients: A Prospective Observational Study

Pretreatment Glasgow Prognostic Score Correlated with Serum Histidine Level and Three-Year Mortality of Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma and Optimal Performance Status